PROCEPT BioRobotics Corp (PRCT) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...

By Yahoo! Finance | Oct 29, 2024 at 03:10 AM EST

Sales rep training impacted Q3 utilization, but September showed strong performance. Q4 expects modest volume impact from ongoing training. ASC pilot program progressing well, expanding in 2025 to boost hospital market penetration. Medicare audits have minimal growth impact. Company targets profitability with strong expense control and gross margin expansion.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.